Home > Press > Cray Reports 2008 Annual and Fourth Quarter Results: Company Posts Record Annual Revenue and Gross Profit
Abstract:
Global supercomputer leader Cray Inc. (NASDAQ: CRAY) today announced 2008 financial results for the full-year and fourth quarter. For 2008, Cray reported revenue of $282.9 million and a net loss of ($31.3 million), or ($0.96) per share. The results include a $54.5 million non-cash goodwill impairment taken in the fourth quarter; without the goodwill impairment, the company would have been solidly profitable for 2008. For 2007, revenue was $186.2 million and net loss was ($5.7 million), or ($0.18) per share. Gross profit for the year was $111.1 million, surpassing the Company's previous high of $98.8 million for 2003.
Revenue for the fourth quarter 2008 was $155.4 million, driven by the acceptance of the approximately $100 million Oak Ridge National Laboratory petaflops system. Revenue was $57.4 million in the fourth quarter of 2007. The company reported a net loss for the quarter of ($20.7 million), or ($0.63) per share, including the goodwill impairment, compared to a net loss of ($3.6 million), or ($0.11) per share, in the fourth quarter 2007. The goodwill impairment will have no effect on Cray's cash balances or cash flow from operating activities, nor any effect on ongoing operations.
Overall gross profit margin for 2008 improved to 39.3 percent compared to 35.1 percent in 2007. Product margin for 2008 improved to 38.9 percent compared to 33.0 percent in 2007, driven primarily by improved product mix. Service margin for 2008 was 40.4 percent. For the fourth quarter 2008, overall gross profit margin was 36.2 percent compared to 29.6 percent in the fourth quarter 2007. Product margin was 35.9 percent compared to 25.9 percent in the prior year period, and fourth quarter 2008 service margin was 38.5 percent.
Core operating expenses, consisting of research and development, sales and marketing, and general and administrative expenses, increased to $93.5 million in 2008 from $75.0 million in 2007. The increase was driven primarily by increased research and development and increased variable compensation, including sales commissions, associated with company performance. Included in the 2008 results were $10.2 million for depreciation and amortization and $3.4 million related to stock compensation. Core operating expenses in the fourth quarter 2008 were $27.2 million compared to $21.9 million in the prior year period. The increase was primarily a result of variable compensation. Included in the fourth quarter 2008 results were non-cash items of $2.2 million for depreciation and amortization and $0.9 million related to stock compensation.
As of December 31, 2008, net cash (cash and short-term investment balances less outstanding convertible notes) was $52.7 million, compared to $23.6 million as of September 30, 2008 and $99.1 million as of December 31, 2007.
"I am very pleased to report one of the strongest years in our company's history and a record year on several fronts," said Peter Ungaro, president and CEO of Cray.
"Our revenue and gross profit results for the year were both records," Ungaro continued. "We delivered on our goal of growth by posting a 52% increase in annual revenue, led by the launch of our XT5 supercomputer, and we were nicely profitable except for the non-cash write-down of goodwill recorded in the fourth quarter. The XT5 'Jaguar' supercomputer at Oak Ridge, which was delivered and accepted in 2008, is the largest system in our history and was the first and only system in the world to break the petaflops performance hurdle on real, scientific applications. Additionally, we made strides in diversifying our revenue base, expanding our addressable market, and improving our balance sheet through opportunistic repurchasing of our convertible notes. With the strength of our supercomputing business and the introductions of our custom engineering initiative and the CX1, we are optimistic that we will achieve our long term goals of both growth and sustained profitability."
Outlook
For 2009, a wide range of potential outcomes remain possible. Cray currently expects revenue in the range of $260 million with a small operating loss. Overall gross margin is expected to decline to the low to mid-30 percent range, driven primarily by the unfavorable impact of a multi-phase contract for approximately $41 million at a low margin. Core operating expenses are anticipated to be lower by roughly $2 million from 2008 levels. We currently anticipate quarterly revenue to be weighted more evenly during 2009 than in previous years, though results will fluctuate depending on the timing of system acceptances.
We expect net cash during 2009 to be generally above the year-end 2008 result.
Recent Highlights
-- During the fourth quarter, Cray successfully installed and received
acceptance for the Cray XT5 supercomputer named "Jaguar" at the Oak Ridge
National Laboratory. With a peak computing power of 1.64 petaflops,
Jaguar is the world's first petaflops system dedicated to open research.
Shortly after installation, an ORNL research team recorded an unprecedented
sustained performance of 1.35 petaflops on a superconductivity application
used in nanotechnology and materials science research.
-- During the fourth quarter, Cray repurchased over $52 million of its
3.0% Convertible Senior Subordinated Notes expected to be put to the
company in December 2009 for approximately $47.6 million plus accrued
interest and broker fees.
-- Cray's CX1 personal supercomputer became generally available during
the fourth quarter. Early adopters include Cray's traditional customer
base such as government institutions, but the company also added customers
in segments not recently served such as petroleum and transportation
companies, and educational institutions. Cray is building a worldwide
channel partner network to respond to demand and interest in the Cray CX1
system.
-- During the fourth quarter, Cray's Custom Engineering group completed
the first phase of a multi-phase contract to design and develop the
infrastructure and system software for a specialized high performance
computer for the U.S. Government.
Conference Call Information
Cray will host a conference call today, Tuesday, February 10, 2009 at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) to discuss fourth quarter and full-year 2008 financial results. To access the call, please dial into the conference at least 10 minutes prior to the beginning of the call at 1-800-366-7640. International callers should dial 303-262-2138. To listen to the live audio webcast, go to the Investors section of the Cray website at investors.cray.com.
If you are unable to attend the live conference call, an audio webcast replay will be available in the Investors section of the Cray website for 180 days. If you do not have Internet access, a replay of the call will be available by dialing 1-800-405-2236 and entering access code 11126368. International callers can listen to the replay by dialing 303-590-3000, access code 11126368. The conference call replay will be available for 72 hours, beginning at 4:30 p.m. Pacific Time on Tuesday, February 10, 2009.
####
About Cray Inc.
As a global leader in supercomputing, Cray provides highly advanced supercomputers and world-class services and support to government, industry and academia. Cray technology enables scientists and engineers to achieve remarkable breakthroughs by accelerating performance, improving efficiency and extending the capabilities of their most demanding applications. Cray's Adaptive Supercomputing vision will result in innovative next-generation products that integrate diverse processing technologies into a unified architecture, allowing customers to surpass today's limitations and meeting the market's continued demand for realized performance. Go to www.cray.com for more information.
Safe Harbor Statement
This press release contains forward-looking statements. There are certain factors that could cause Cray's execution to differ materially from those anticipated by the statements above. These factors include significantly fluctuating quarterly operating results; significant reliance on third-party development service and parts suppliers; lower margin and operating results due to many variables including pricing pressure from competitive products and increasing pressure on research and development expenses; the technical challenges of developing high performance computing systems, including potential delays in development programs; the level, timing and continuation of government funding for supercomputer purchases and research and development activities, including the possible adverse effects of the current economic uncertainty on government budgets; the successful porting of application programs to Cray supercomputer systems; winning new Custom Engineering contracts for 2009 performance; successful rate of customer adoption of the Cray CX1 system; anticipated revenue subject to complex revenue recognition rules; the successful passing of customer acceptance tests; Cray's ability to compete against larger, more established companies and innovative competitors; and general economic and market conditions. For a discussion of these and other risks, see "Risk Factors" in Cray's most recent Quarterly Report on Form 10-Q filed with the SEC.
Cray is a registered trademark, and Cray XT5 and Cray CX1 are trademarks of Cray Inc. All other trademarks are the property of their respective owners.
CRAY INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited and in thousands, except per share data) Three Months Ended Year Ended December 31, December 31, 2008 2007 2008 2007 --------- --------- --------- --------- REVENUE: Product $ 137,364 $ 43,264 $ 218,970 $ 133,455 Service 18,035 14,166 63,883 52,698 --------- --------- --------- --------- Total revenue 155,399 57,430 282,853 186,153 --------- --------- --------- --------- COST OF REVENUE: Cost of product revenue 88,034 32,053 133,715 89,475 Cost of service revenue 11,100 8,367 38,062 31,247 --------- --------- --------- --------- Total cost of revenue 99,134 40,420 171,777 120,722 --------- --------- --------- --------- Gross profit 56,265 17,010 111,076 65,431 --------- --------- --------- --------- OPERATING EXPENSES: Research and development, net 13,802 12,077 51,775 37,883 Sales and marketing 7,623 6,323 24,988 22,137 General and administrative 5,806 3,514 16,742 14,956 Restructuring, severance and impairment 54,450 (58) 54,450 (48) --------- --------- --------- --------- Total operating expenses 81,681 21,856 147,955 74,928 --------- --------- --------- --------- Loss from operations (25,416) (4,846) (36,879) (9,497) Other income (expense), net 4,772 347 5,133 1,112 Interest income (expense), net 37 1,125 787 3,840 --------- --------- --------- --------- Loss before income taxes (20,607) (3,374) (30,959) (4,545) Income tax expense (85) (221) (387) (1,174) --------- --------- --------- --------- Net loss $ (20,692) $ (3,595) $ (31,346) $ (5,719) ========= ========= ========= ========= Diluted net loss per common share $ (0.63) $ (0.11) $ (0.96) $ (0.18) ========= ========= ========= ========= Diluted weighted average shares outstanding 32,769 32,242 32,573 31,892 ========= ========= ========= ========= CRAY INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited and in thousands) December 31, December 31, 2008 2007 ------------ ------------ ASSETS Current assets: Cash and cash equivalents $ 72,373 $ 120,539 Restricted cash 2,691 10,000 Short term investments, available-for-sale 5,350 48,582 Accounts receivable, net 95,667 23,635 Inventory 80,437 55,608 Prepaid engineering services 16,458 - Prepaid expenses and other current assets 13,565 4,120 ------------ ------------ Total current assets 286,541 262,484 Property and equipment, net 18,396 17,044 Service inventory, net 1,917 2,986 Goodwill - 65,411 Deferred tax asset 1,200 512 Other non-current assets 5,837 7,465 ------------ ------------ TOTAL ASSETS $ 313,891 $ 355,902 ============ ============ LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities: Accounts payable $ 16,730 $ 14,148 Accrued payroll and related expenses 23,672 12,023 Other accrued liabilities 24,670 7,488 Advance research and development payments 13,887 29,669 Convertible notes payable 27,727 - Deferred revenue 67,692 48,317 ------------ ------------ Total current liabilities 174,378 111,645 Long-term deferred revenue 18,154 11,745 Other non-current liabilities 3,170 4,310 Non-current convertible notes payable - 80,000 ------------ ------------ TOTAL LIABILITIES 195,702 207,700 Shareholders' equity: Common stock 518,727 513,196 Accumulated other comprehensive income 9,364 13,562 Accumulated deficit (409,902) (378,556) ------------ ------------ TOTAL SHAREHOLDERS' EQUITY 118,189 148,202 ------------ ------------ TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY $ 313,891 $ 355,902 ============ ============
For more information, please click here
Contacts:
Cray Media:
Nick Davis
206/701-2123
Investors:
Paul Hiemstra
206/701-2044
Copyright © Marketwire
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Financial Reports
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
Events/Classes
A New Blue: Mysterious origin of the ribbontail ray’s electric blue spots revealed July 5th, 2024
Researchers demonstrate co-propagation of quantum and classical signals: Study shows that quantum encryption can be implemented in existing fiber networks January 20th, 2023
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||